Hormonal Birth Control

In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.

Support for the integration of reproductive health care in the primary care setting, noncontraceptive benefits of hormonal contraception, use of patient decision aids in shared decision making in obstetrics and gynecology care, and more.

What providers need to know about telehealth options for birth control, STI, abortion, and more.

An analysis of the benefits and risks of immediate postpartum IUD insertion, demonstrated improved health outcomes for society as a whole with universal access to contraception, a systematic review of studies of the efficacy and safety of extended IUD use, and more.

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

The FDA has extended approval of LILETTA IUDs for up to 6 years of use, research shows they are safe and effective for up to 7 years.

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.